论文部分内容阅读
目的了解延髓麻痹患者并发肺部感染的病原菌流行及耐药情况。方法采用回顾性调查的方法,对延髓麻痹患者212例,分析其肺部感染病原菌分布特点及耐药率。结果212例延髓麻痹患者并发肺部感染发生率为30.2%(64例),比同期同病房患者并发肺部感染发生率(2.1%)高;延髓麻痹并发肺部感染的感染菌以革兰阳性菌为主,占68.8%,革兰阳性菌中又以金黄色葡萄球菌为主。结论延髓麻痹并发肺部感染且病情危重者,如影像学资料及痰涂片结果支持金黄色葡萄球菌感染,可考虑万古霉素治疗。
Objective To understand the prevalence and drug resistance of pathogens in patients with bulbar paralysis complicated by pulmonary infection. Methods A retrospective survey of 212 cases of bulbar paralysis patients, analysis of the distribution of pulmonary pathogens and drug resistance rates. Results The incidence of pulmonary infection in 212 patients with bulbar paralysis was 30.2% (64 cases), which was higher than that of the same ward (2.1%) in the same ward. The infected bacteria with bulbar paralysis complicated with pulmonary infection were Gram-positive Mainly accounted for 68.8% of the bacteria, but Staphylococcus aureus was the main gram-positive bacteria. Conclusions Bulbar paralysis associated with pulmonary infection and critically ill patients, such as imaging data and sputum smear results support the infection of Staphylococcus aureus, can be considered vancomycin treatment.